Yuekang Pharmaceutical: Net loss of 254 million yuan in 2025

2026-03-29 19:21:22

Yuekang Pharmaceutical releases a performance quick report. In 2025, the company achieved total operating revenue of 2.446 billion yuan, down 35.30% year over year. It recorded an operating profit of -225 million yuan, down 241.70% year over year. Net profit attributable to shareholders of the parent company was -254 million yuan, down 305.18% year over year. Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was -280 million yuan, down 352.83% year over year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.